Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. - Wikidata - wikimedia - TriplyDB

Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience.

Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience.

http://www.wikidata.org/entity/Q35581017

about

Self-reported and actual beta-blocker prescribing for heart failure patients: physician predictors.Cardiopulmonary exercise testing is equally prognostic in young, middle-aged and older individuals diagnosed with heart failure.Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010.Translation of clinical trials into clinical practice.What can we learn from Europe?Brief report: beta-blocker use among veterans with systolic heart failure Early initiation of beta blockade in heart failure: issues and evidence.Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure.Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry.Beta-blocker therapy of heart failure: an update.Nebivolol for heart failure in the elderly.Carvedilol in the treatment of elderly patients with chronic heart failure.Factors associated with β-blocker initiation and discontinuation in a population-based cohort of seniors newly diagnosed with heart failure.Beta-blockers and ivabradine in chronic heart failure: from clinical trials to clinical practice.Use of noninvasive hemodynamics to aid decision making in the initiation and titration of neurohormonal agents.Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study.Programme to improve the use of beta-blockers for heart failure in the elderly and in those with severe symptoms: results of the BRING-UP 2 Study.Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome.Clinical tolerability of generic versus brand beta blockers in heart failure with reduced left ventricular ejection fraction: a retrospective cohort from heart failure clinic.Treatment with beta-blockers in nurse-led heart failure clinics: titration efficacy and predictors of failure.Unreliability of the %VO2 reserve versus %heart rate reserve relationship for aerobic effort relative intensity assessment in chronic heart failure patients on or off beta-blocking therapy.Association is not causation: treatment effects cannot be estimated from observational data in heart failure

P2860

Q33521687-25F2C99F-A5FB-4232-9DD9-431055192CF4 Q34166467-32D595BD-116B-441B-9D5A-288723E86BD8 Q34383304-1342A982-54F8-42D6-8E4A-5CC9DF7DB6DE Q35556751-B9727B21-EF3C-4B7C-9F93-0A4E52806F00 Q35661128-7D8D1A92-9AB3-436D-9DEF-2759CD50F963 Q35808277-19E28BE1-06CE-4134-B3D7-2F3FA2C273B0 Q35901592-4029B5CD-AC35-415F-B831-E41CA51AD2BF Q36287752-CA6D546B-9172-4099-8F9F-DEFCDD3B0A4E Q36675400-86BCB25C-F34D-4175-9B16-7ABF74CAE630 Q36684047-03FED3A5-E92A-484E-90EF-3541DE1F7868 Q36723828-1F282150-31F1-4120-AD2B-14244C025EEE Q36815960-71F482BC-7363-41B4-8373-77F1DC98D19F Q36892905-1459FAA4-61DE-4E3A-A22D-712E44212D16 Q37269746-FE34AE89-133F-4B73-82DC-86194074B616 Q38170307-BC2BE889-C075-4557-A211-893D53717A27 Q44836960-C83937F8-5041-4FE7-8E4F-E82291A2F751 Q46435130-9F62518A-60DD-4F1A-B911-626B5DC50DB4 Q46640341-ABFD38C4-8E3A-4477-A2F2-B4721CDA4CBE Q46731180-B68A8850-3DB1-41E0-A5CE-E12724FB6206 Q46934841-0FE38D06-1A07-4584-9499-5BEF1A3B0BBC Q47339351-A7388A59-0014-46BB-B3BA-6F3A9268CD5D Q49591511-664ABD20-043A-48A7-9D17-CF6F099A095E Q51750062-FA6F0A08-1CF8-40E5-8FC6-E7DC7006E62E Q53794648-31BC26BA-D309-441D-AAD8-5DBF6FD4EC81 Q58804164-55E1DF65-E92C-4A98-B3BB-A8A4600958F8

P2860

Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience.

http://www.wikidata.org/entity/Q35581017

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Treatment of chronic heart fai ...... ials: the BRING-UP experience.

@ast

Treatment of chronic heart fai ...... ials: the BRING-UP experience.

@en

type

label

Treatment of chronic heart fai ...... ials: the BRING-UP experience.

@ast

Treatment of chronic heart fai ...... ials: the BRING-UP experience.

@en

prefLabel

Treatment of chronic heart fai ...... ials: the BRING-UP experience.

@ast

Treatment of chronic heart fai ...... ials: the BRING-UP experience.

@en

P1433

Q35581017-BCAAAC7C-DF4D-41A8-AE43-92EFE7333BE2

P1476

Q35581017-52418C8E-5783-42F9-862B-240F9B573304

P2093

Q35581017-07B2D085-B39B-4035-9F60-17A95418E1A3

Q35581017-20ACFDDE-6C8E-4140-8113-7730086E5B4F

Q35581017-30D6D700-204F-4D5E-9101-508994972753

Q35581017-456CE850-AAAE-4F95-84E1-A962601E8793

Q35581017-9C07C4D5-4919-42C4-A6E1-F9704066F818

Q35581017-A69E2DE8-9588-415D-AC83-4DE57AA7440C

Q35581017-B626ADE7-C209-4B27-A7D2-C48487C1632B

Q35581017-B77C7F0E-B1C1-481B-BB7F-7E6452E75326

Q35581017-C0EFD91A-5421-47A5-ADAF-5343F846B552

Q35581017-D331EE68-B518-4E47-B62D-908E6B071323

P2860

Q35581017-002D1C7F-FD6C-4CDC-BD56-7C4F200DA25C

Q35581017-129A0C36-7FE5-43BA-A724-80C6119D8DE9

Q35581017-1FB5C078-2FE2-4DC2-95DB-D45CFF5629B2

Q35581017-4D946B57-20D2-45A6-ACA1-12F498E1599B

Q35581017-50461CEE-838A-4228-9B01-034649B1B2F9

Q35581017-533F3C92-E142-4F0D-9E86-DBE1374BB06B

Q35581017-61CD7E7E-AAB5-4BA2-A2B5-66B3ADF303A2

Q35581017-8405EB9C-472B-4EF7-8C12-242AC17EDA83

Q35581017-87AF7D28-3EFC-453F-8C4A-3963DCDE1454

Q35581017-A620A6FA-7CDA-46D1-B96B-FFFDAFB17D1D

P304

Q35581017-B563AC8E-88E2-47C2-AFDD-6309F74C3F6D

P31

Q35581017-7FD4BBBE-F0C3-4A1A-8ACD-B464132D01F6

P356

Q35581017-05725D7B-8A56-4CC6-9D01-95A4C088EE39

P407

Q35581017-FF910305-0E33-4AEB-B9ED-2F8FEBACE89F

P433

Q35581017-4F4604C0-8B78-4075-BBE1-E2801CA1B99D

P478

Q35581017-6124E8CA-A744-4CF7-AECE-3C5146C7645C

P577

Q35581017-583B9A78-CB6D-4D12-8E2F-FCB472E1994C

P5875

Q35581017-7D3005AB-208E-4E58-A672-730F5CCBB04C

P698

Q35581017-7ECB6E93-8430-4B52-832F-458C2FF775AD

P921

Q35581017-2812BF85-D1E6-4365-8C2D-0EFB4DFC12D9

P932

Q35581017-3A062501-A02D-4BC0-BF42-459B25543F29

P356

P1433

P1476

Treatment of chronic heart fai ...... ials: the BRING-UP experience.

@en

P2093

A P Maggioni

http://www.w3.org/2001/XMLSchema#string

Beta blockers in patients with ...... linical practice Investigators

http://www.w3.org/2001/XMLSchema#string

C Opasich

http://www.w3.org/2001/XMLSchema#string

D Lucci

http://www.w3.org/2001/XMLSchema#string

E Balli

http://www.w3.org/2001/XMLSchema#string

E Geraci

http://www.w3.org/2001/XMLSchema#string

E Gronda

http://www.w3.org/2001/XMLSchema#string

G Sinagra

http://www.w3.org/2001/XMLSchema#string

G Tognoni

http://www.w3.org/2001/XMLSchema#string

L Tavazzi

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized, controlled trials, observational studies, and the hierarchy of research designs

Health services: an Italian market.

Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.

Major beta blocker mortality trials in chronic heart failure: a critical review.

beta-adrenergic receptor blockade in chronic heart failure.

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

A comparison of observational studies and randomized, controlled trials.

Beta-blockers: the new standard of therapy for mild heart failure.

Effect of carvedilol on survival in severe chronic heart failure.

A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

P304

299-305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HEART.89.3.299

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10895543

http://www.w3.org/2001/XMLSchema#string

P698

12591836

http://www.w3.org/2001/XMLSchema#string

P921

P932

1767602

http://www.w3.org/2001/XMLSchema#string